GlaxoSmithKline's market cap is currently $73.72B. The company's EPS TTM is $1.6; its P/E ratio is 22.41; and it has a dividend yield of 4.23%. GlaxoSmithKline is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is $1.02. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	£ 30.33B	£ 29.32B	£ 34.11B	£ 34.10B	£ 33.75B
Gross Profit	£ 21.76B	£ 19.77B	£ 22.51B	£ 22.39B	£ 21.89B
Operating Income	£ 6.75B	£ 6.43B	£ 4.36B	£ 5.98B	£ 6.96B
EBITDA	£ 9.14B	£ 8.60B	£ 7.76B	£ 8.10B	£ 9.43B
Net Income	£ 4.93B	£ 14.96B	£ 4.38B	£ 5.75B	£ 4.64B
Balance Sheet
Cash & Short-Term Investments	£ 4.99B	£ 7.88B	£ 4.33B	£ 6.37B	£ 4.79B
Total Assets	£ 59.01B	£ 60.15B	£ 79.10B	£ 80.43B	£ 79.69B
Total Debt	£ 18.02B	£ 20.99B	£ 24.17B	£ 27.15B	£ 30.51B
Net Debt	£ 15.27B	£ 17.26B	£ 19.90B	£ 20.86B	£ 25.80B
Total Liabilities	£ 46.21B	£ 50.05B	£ 57.76B	£ 59.62B	£ 61.34B
Stockholders' Equity	£ 13.35B	£ 10.60B	£ 15.05B	£ 14.59B	£ 11.98B
Cash Flow
Free Cash Flow	£ 4.42B	£ 5.14B	£ 5.02B	£ 6.20B	£ 5.86B
Operating Cash Flow	£ 6.77B	£ 7.40B	£ 7.95B	£ 8.44B	£ 8.02B
Investing Cash Flow	£ -1.59B	£ -8.77B	£ -1.78B	£ 2.16B	£ -5.35B
Financing Cash Flow	£ -5.64B	£ 823.00M	£ -7.59B	£ -10.13B	£ -1.84B

Currency in GBP

GlaxoSmithKline Earnings and Revenue History

Income Statement >

GlaxoSmithKline Debt to Assets

Balance Sheet >

GlaxoSmithKline Cash Flow

Cash Flow >

GlaxoSmithKline Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing